Baseline GA measure scores among older adults initiating induction chemotherapy for AML (N = 74)
GA scores . | Median (25th, 75th) . | % Impaired . |
---|---|---|
Cognition | ||
3MS (range 0-100, impairment < 77) | 85.0 (75.0, 91.0) | 28.8 |
Psychological function | ||
CES-D (range 0-60, impairment > 16) | 11.0 (4.0, 21.0) | 39.7 |
DT (range 0-10, impairment ≥ 4) | 5.0 (2.0, 8.0) | 58.9 |
PF | ||
PAT-D* (range 1-5, impairment > 1) at the time of treatment | 1.4 (1.0, 1.8) | 72.4 |
ADL subscale | 1.0 (1.0, 1.4) | 50.0 |
IADL subscale | 1.0 (1.0, 1.7) | 40.5 |
Mobility subscale | 2.0 (1.0, 3.0) | 68.9 |
PAT-D* 6-mo recall | 1.1 (1.0, 1.3) | |
ADL subscale | 1.0 (1.0, 1.0) | 23.3 |
IADL subscale | 1.0 (1.0, 1.0) | 20.6 |
Mobility subscale | 1.0 (1.0, 1.7) | 41.1 |
SPPB (range 0-12, impairment < 9) | 8.5 (3.0, 10.0) | 50.0 |
Grip strength (kg)† | ||
Male | 38.0 (32.0, 44.0) | |
Female | 24.0 (22.0, 28.0) | |
Comorbidity | ||
HCT-CI (impairment > 1) | 1.0 (0.0, 3.0) | 41.9 |
GA scores . | Median (25th, 75th) . | % Impaired . |
---|---|---|
Cognition | ||
3MS (range 0-100, impairment < 77) | 85.0 (75.0, 91.0) | 28.8 |
Psychological function | ||
CES-D (range 0-60, impairment > 16) | 11.0 (4.0, 21.0) | 39.7 |
DT (range 0-10, impairment ≥ 4) | 5.0 (2.0, 8.0) | 58.9 |
PF | ||
PAT-D* (range 1-5, impairment > 1) at the time of treatment | 1.4 (1.0, 1.8) | 72.4 |
ADL subscale | 1.0 (1.0, 1.4) | 50.0 |
IADL subscale | 1.0 (1.0, 1.7) | 40.5 |
Mobility subscale | 2.0 (1.0, 3.0) | 68.9 |
PAT-D* 6-mo recall | 1.1 (1.0, 1.3) | |
ADL subscale | 1.0 (1.0, 1.0) | 23.3 |
IADL subscale | 1.0 (1.0, 1.0) | 20.6 |
Mobility subscale | 1.0 (1.0, 1.7) | 41.1 |
SPPB (range 0-12, impairment < 9) | 8.5 (3.0, 10.0) | 50.0 |
Grip strength (kg)† | ||
Male | 38.0 (32.0, 44.0) | |
Female | 24.0 (22.0, 28.0) | |
Comorbidity | ||
HCT-CI (impairment > 1) | 1.0 (0.0, 3.0) | 41.9 |
For 3MS, SPPB, and grip strength, a higher score reflects better function. For CES-D, DT, PAT-D, and HCT-CI, a higher score reflects worse function.
ADL, Activities of Daily Living; DT, Distress Thermometer; HCT-CI, Hematopoietic Stem Cell Transplantation Comorbidity Index; IADL, Instrumental Activities of Daily Living; PAT-D, Pepper Assessment Tool for Disability.
Results based on subjects with calculable survey scores (reported in Results section).
Scores are based on 67 subjects who performed grip strength.